Table 1.
Demographics and clinical characteristics of the two groups.
| Characteristics | Fistuloclysis (n = 35) | Control (n = 60) | P value |
|---|---|---|---|
| Age (years) | 50.2 ± 14.1 | 55.8 ± 11.2 | 0.687 |
| Male, n (%) | 24 (68.6) | 37 (61.7) | 0.650 |
| BMI (kg/m2) | 19.1 ± 3.5 | 19.7 ± 2.3 | 0.627 |
| Scores on admission | |||
| APACHE II (24 h) | 11.5 ± 3.0 | 12.2 ± 2.6 | 0.208 |
| SOFA (24 h) | 4.5 ± 1.2 | 4.8 ± 1.1 | 0.071 |
| Etiology, n (%) | |||
| Trauma | 14 (40.0) | 22 (36.7) | 0.747 |
| Tumor | 3 (8.6) | 7 (11.7) | 0.637 |
| Ischemic enteropathy | 1 (2.9) | 1 (1.7) | 0.698 |
| Operations | 10 (28.6) | 13 (21.7) | 0.449 |
| Pancreatitis | 5 (14.3) | 8 (13.3) | 0.897 |
| IBD | 2 (5.7) | 9 (15.0) | 0.175 |
| Fistula locations, n (%) | |||
| Jejunal-ileal | 11 (31.4) | 20 (33.3) | 0.849 |
| Biliary | 16 (45.7) | 3 (5.0) | 0.042* |
| Duodenal | 8 (22.9) | 37 (61.7) | 0.033* |
| Underlying disease, n (%) | |||
| Cancer | 6 (17.1) | 7 (11.7) | 0.456 |
| Cardiovascular disease | 2 (5.7) | 2 (3.3) | 0.579 |
| Diabetes | 4 (11.4) | 2 (3.3) | 0.120 |
| COPD | 6 (17.1) | 12 (20.0) | 0.732 |
| None | 18 (51.4) | 37 (61.7) | 0.330 |
| Charges ($), mean ± SD | 30215.1 ± 6518.9 | 44261.3 ± 5631.2 | <0.001* |
| Hospital stay (days), mean ± SD | 56.2 ± 24.3 | 74.6 ± 19.8 | <0.001* |
| Hospital mortality, n (%) | 0 (0) | 5 (8.3) | 0.025* |
BMI: body mass index; APACHE II: acute physiology score and chronic health evaluation II; SOFA: sequential organ failure assessment score; IBD: inflammatory bowel disease; COPD: chronic obstructive pulmonary disease. Data were presented as mean ± SD. P value < 0.05 was deemed significant.